TBPH vs MSFT: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Microsoft Corp in 2026
TBPH
Theravance Biopharma Inc
$17.23
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | TBPH | MSFT | Winner |
|---|---|---|---|
| Market Cap | $864.05M | N/A | TBPH |
| P/E Ratio | 8.15 | 26.32 | TBPH |
| EPS (TTM) | $2.06 | $15.97 | MSFT |
| Revenue Growth | 1.4% | 0.2% | TBPH |
| Gross Margin | 65.2% | 68.6% | MSFT |
Analyze TBPH
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or MSFT a better investment?
Comparing TBPH and MSFT: Theravance Biopharma Inc has a market cap of $864.05M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and MSFT?
TBPH (Theravance Biopharma Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or MSFT?
Based on P/E ratios, TBPH trades at a lower multiple (8.1x vs 26.3x).
Which is growing faster: TBPH or MSFT?
TBPH has higher revenue growth at 1.4% vs 0.2% for MSFT.
Which company is more profitable: TBPH or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 65.2% for TBPH.
Which is the larger company: TBPH or MSFT?
Theravance Biopharma Inc (TBPH) is larger with a market cap of $864.05M compared to N/A for MSFT.
Should I buy TBPH or MSFT in 2026?
Both TBPH and MSFT have investment merit. TBPH trades at $17.23 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and MSFT stock?
Key differences: Market Cap ($864.05M vs N/A), P/E Ratio (8.1x vs 26.3x), Revenue Growth (1.4% vs 0.2%), Gross Margin (65.2% vs 68.6%).